Solution Properties and Pharmaceutical Formulations

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/59

flashcard set

Earn XP

Description and Tags

Vocabulary practice flashcards covering solution properties, colligative properties, buffers, tonicity, drug absorption factors, excipients, solid-state forms, and delivery considerations.

Last updated 7:01 PM on 9/7/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

60 Terms

1
New cards

pH = pKa Ionization State

The state in which a drug or substance is 50% ionized and 50% non-ionized.

2
New cards

Optimal Buffer Condition

The condition met when pH=pKa\text{pH} = \text{pKa}, allowing a buffer solution to work at its best.

3
New cards

Effective Range of a Buffer

The operational pH range of a buffer, defined as pKa±1pH unit\text{pKa} \pm 1\,\text{pH unit}.

4
New cards

Pharmaceutical Buffer

A solution component designed to resist pH changes and maintain stability, solubility, and patient comfort.

5
New cards

Four Colligative Properties

Vapor pressure lowering, boiling point elevation, freezing point depression, and osmotic pressure.

6
New cards

Colligative Properties Basis

Physical properties that depend on the number of dissolved particles, not the identity of the particles.

7
New cards

Effect of Dissolved Particles on Osmotic Pressure

An effect where having more dissolved particles causes osmotic pressure to increase.

8
New cards

Effect of Dissolved Particles on Boiling Point

An effect where having more dissolved particles causes boiling point to increase.

9
New cards

Effect of Dissolved Particles on Freezing Point

An effect where having more dissolved particles causes freezing point to decrease.

10
New cards

Effect of Dissolved Particles on Vapor Pressure

An effect where having more dissolved particles causes vapor pressure to decrease.

11
New cards

Van't Hoff Factor (ii)

The number of particles produced when a solute dissolves in a solvent.

12
New cards

Van't Hoff Factor for Sugar

A value equal to 11, indicating that sugar does not dissociate into multiple particles.

13
New cards

Van't Hoff Factor for NaCl

A value equal to 22, representing the number of particles produced when sodium chloride dissolves.

14
New cards

Van't Hoff Factor for CaCl2\text{CaCl}_2

A value equal to 33, representing the number of particles produced when calcium chloride dissolves.

15
New cards

Osmotic Pressure Dependence on Van't Hoff Factor

Osmotic pressure increases as the Van't Hoff factor increases because more particles are present.

16
New cards

Isotonic NaCl Concentration

A sodium chloride solution concentration of 0.9% NaCl0.9\%\text{ NaCl}.

17
New cards

Hypotonic Solution Effect on Red Blood Cells

Causes water to enter the cells, leading to hemolysis.

18
New cards

Hemolysis

The swelling and bursting of red blood cells.

19
New cards

Hypertonic Solution Effect on Red Blood Cells

Causes water to leave the cells, leading to crenation.

20
New cards

Crenation

The shrinkage and wrinkling of red blood cells.

21
New cards

Isotonicity Freezing-Point Depression

The freezing-point depression value corresponding to isotonicity, defined as ΔTf=0.52C\Delta T_f = 0.52^\circ\text{C}.

22
New cards

Solubility

The amount of drug that can dissolve in a solvent.

23
New cards

Importance of Solubility

The principle that a drug must dissolve before it can be absorbed.

24
New cards

Dissolution

The rate at which a drug dissolves.

25
New cards

Bioavailability Impact of Dissolution

Faster dissolution generally leads to faster absorption and improved bioavailability.

26
New cards

Diffusion

Movement of molecules or particles from high concentration to low concentration.

27
New cards

Permeability

The ability of a drug to cross biological membranes.

28
New cards

Bioavailability

The fraction of drug that reaches systemic circulation.

29
New cards

Determinants of Bioavailability

Solubility, dissolution, diffusion, permeability, and ionization.

30
New cards

Viscosity

The resistance of a liquid to flow.

31
New cards

Viscosity Comparison: Water vs. Syrup

Syrup has a higher viscosity than water.

32
New cards

Viscosity Effect on Suspension Stability

Higher viscosity improves stability and decreases sedimentation.

33
New cards

Disadvantages of High Viscosity

Makes formulations harder for pouring, dosing, and injection.

34
New cards

Purpose of Polymers in Formulations

Controlling drug release and improving formulation stability.

35
New cards

Dosage Forms Commonly Using Polymers

Extended-release and controlled-release dosage forms.

36
New cards

Excipient

An inactive ingredient in a formulation.

37
New cards

Benzalkonium Chloride

An excipient that functions as a preservative.

38
New cards

Boric Acid and Sodium Borate

Excipients that function as buffering agents.

39
New cards

Sodium Chloride in Formulations

An excipient used for tonicity adjustment.

40
New cards

Dextrose in Formulations

An excipient used for tonicity adjustment.

41
New cards

Crystalline Drug Form

A drug structure characterized by an ordered structure, greater stability, and lower solubility.

42
New cards

Amorphous Drug Form

A drug structure characterized by a disordered structure, greater solubility, faster dissolution, and lower stability.

43
New cards

Polymorphism

The ability of the same drug to exist in different crystal forms.

44
New cards

Importance of Polymorphism

Different polymorphs can have different stability, solubility, and bioavailability.

45
New cards

Precipitation

The process of a drug coming out of solution.

46
New cards

Consequences of Precipitation

It can reduce potency, stability, and effectiveness.

47
New cards

Dose Dumping

Sudden release of a large amount of drug from a controlled-release dosage form.

48
New cards

Danger of Dose Dumping

It can cause toxicity.

49
New cards

Incompatibility

An undesirable interaction between formulation components.

50
New cards

Consequences of Improper Storage

Can cause drug degradation, instability, and loss of potency.

51
New cards

Essential Ophthalmic Product Properties

Proper pH, proper tonicity, and sterility.

52
New cards

Spacer with a pMDI Inhaler

A device attachment that improves lung deposition and decreases throat deposition.

53
New cards

Primary Beneficiaries of Spacers

Children, older adults, and patients with poor inhaler coordination.

54
New cards

Weak Acid Form at pH<pKa\text{pH} < \text{pKa}

The state in which the non-ionized form (HA\text{HA}) predominates.

55
New cards

Weak Acid Form at pH>pKa\text{pH} > \text{pKa}

The state in which the ionized form (A\text{A}^-) predominates.

56
New cards

Weak Base Form at pH<pKa\text{pH} < \text{pKa}

The state in which the ionized form (BH+\text{BH}^+) predominates.

57
New cards

Weak Base Form at pH>pKa\text{pH} > \text{pKa}

The state in which the non-ionized form (B\text{B}) predominates.

58
New cards

Colligative Properties Summary Rule

More particles results in \uparrow osmotic pressure, \uparrow boiling point, \downarrow freezing point, and \downarrow vapor pressure.

59
New cards

Systemic Circulation Target

The body's central blood stream reached by the fraction of drug measured as bioavailability.

60
New cards

Sedimentation in Suspensions

The settling of particles in a liquid suspension, which decreases as viscosity increases.